The University of Alabama in Birmingham runs one of an elite group of Comprehensive Cancer Centers in the United States, as designated by the National Cancer Institute (NCI). The NCI's Translational Research Program is in charge of administering SPORE awards, which are focused on specific organ sites. Now UAB is also a SPORE grantee for its brain tumor program, thanks to a recent $2.3M award over three years to its Cancer Center in conjunction with the UAB Division of Neurosurgery. UAB is one of only four institutions to receive a brain-tumor SPORE grant.
According to Dr. G. Yancey Gillespie, Ph.D., professor of surgery:
The SPORE research that Dr. Gillespie and his colleagues will be conducting, to develop new therapies, targets anaplastic gliomas, the most deadly and frequent form of malignant brain tumors. Two specific projects they will pursue under the grant are:
In addition to the recent SPORE grant, the UAB Comprehensive Cancer Center has received a five-year, $27.5M Cancer Center Support Grant from the National Cancer Institute to renew support for its cancer research program through 2016. The UAB Cancer Center will receive more than $5.4 million per year to support six research programs, plus 14 shared facilities and services.
(Image courtesy of the University of Alabama, Birmingham Comprehensive Cancer Center)
Biotechnology Calendar Inc. will be on the UAB campus on November 1, 2012 for our 13th Annual Birmingham BioResearch Product Faire™ event, where life science researchers and equipment vendors meet and discuss the latest laboratory technologies. For more information on exhibiting, click the button below: